Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation

<p>Overview of Kaplan-Meier curves for several investigated genetic markers in 89 OL samples. On the y-axis the fraction remaining free of malignant transformation over time is shown. The x-axis shows the time in years. The table below the figure specifies the number of patients at risk at the...

Saved in:

書目詳細資料
主要作者:	Leon J. Wils (15055780) (author)
其他作者:	Jos B. Poell (15055783) (author), Arjen Brink (15055786) (author), Ilkay Evren (15055789) (author), Elisabeth R. Brouns (15055792) (author), Jan G.A.M. de Visscher (15055795) (author), Elisabeth Bloemena (15055798) (author), Ruud H. Brakenhoff (15055801) (author)
出版:	2025
主題:	Cancer Cancer Biology Tumor Biology Cancer Detection and Diagnosis Methods and Technology Cancer Prevention Epidemiology Biomarkers Genetic biomarkers Cancer risk assessment Carcinogenesis Premalignancy Computational Methods Sequence analysis Gene Technologies Mutation detection methods Genetics of Cancer Risk & Outcome Head, Neck & Oral Cancers Progression, Invasion & Metastasis Tumor progression
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S12 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S2 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S4 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S5 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S6 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S7 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S8 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Figure S9 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
由: Leon J. Wils (15055780)
出版: (2025)

Supplementary Data 1 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
由: Priyanka Gopal (15050862)
出版: (2025)

Supplementary Data 2 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
由: Priyanka Gopal (15050862)
出版: (2025)

Supplementary Data 3 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
由: Priyanka Gopal (15050862)
出版: (2025)

Supplementary Data 4 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
由: Priyanka Gopal (15050862)
出版: (2025)

Supplementary Data 5 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
由: Priyanka Gopal (15050862)
出版: (2025)

Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
由: Priyanka Gopal (15050862)
出版: (2025)

Supplementary Table S4 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
由: Chaoyang Zhang (15051876)
出版: (2025)

Supplementary Table S6 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
由: Chaoyang Zhang (15051876)
出版: (2025)

Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
由: Raphaël Leman (17314506)
出版: (2025)

Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
由: Raphaël Leman (17314506)
出版: (2025)

Supplementary Table S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
由: Raphaël Leman (17314506)
出版: (2025)

Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
由: Raphaël Leman (17314506)
出版: (2025)

Supplementary Table S5 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
由: Raphaël Leman (17314506)
出版: (2025)

Supplementary Table S6 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
由: Raphaël Leman (17314506)
出版: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
由: Lenka Stolarova (16547259)
出版: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
由: Lenka Stolarova (16547259)
出版: (2025)

Table S3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
由: Lenka Stolarova (16547259)
出版: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
由: Shuwei Li (16437116)
出版: (2025)

Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
由: Ismael Fernández-Miranda (15051932)
出版: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
由: Josephine K. Dermawan (17079555)
出版: (2025)

Figure 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Figure 2 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Figure 3 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Figure 4 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Figure 5 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Figure 6 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Supplementary Table 4: SpatialDecon derived immune cell counts from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Supplementry Table 3: REACTOME Gene Set Enrichment Analysis results from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Table 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
由: Colin S. Wood (15293247)
出版: (2025)

Supplementary table S2 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
由: Leon P. Loevenich (14963948)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_5btesurj3iga7ppq851tja9hrd